United-Guardian, Inc. (UG)

♥ 564 Thanks from members

United-Guardian, Inc. (UG) demonstrates solid financial growth in Q2 and H1 2026, driven by cosmetic ingredients and pharmaceutical demand. Despite strong top-line and net income performance, market reaction remains muted, balancing high fundamental quality scores against cautious valuation models.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ

Microchip Technology Incorporated (MCHP)

NASDAQ

Direxion Daily AAPL Bear 1X ETF (AAPD)

NASDAQ

Ascentage Pharma Group International - American Depository Shares (AAPG)

NASDAQ

Direxion Daily AAPL Bull 2X ETF (AAPU)

NASDAQ

Alpha Blue Capital US Small-Mid Cap Dynamic ETF (ABCS)

NASDAQ

AbCellera Biologics Inc. - Common Shares (ABCL)

Entity & Market Metadata

Sector: Healthcare Industry: Specialty Chemicals Founder: Company Founders Leadership: Merryl Moskowitz (CEO) Leadership: Ann Marie Hughes (CFO) Holder: Renaissance Technologies Holder: Dimensional Fund Advisors Holder: Vanguard Group Lubricants Cosmetic Ingredients Pharmaceutical Excipients #UG #United-Guardian #Specialty Chemicals #Cosmetic Ingredients Stock #NASDAQ UG